Viracta Therapeutics, Inc.盘中异动股价大跌5.71%报0.200美元

市场透视12-17

北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.18倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492966392?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-17 22:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492966392","market":"us","top_or_hot":-1,"title":"Viracta Therapeutics, Inc.盘中异动 股价大跌5.71%报0.200美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.18倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viracta Therapeutics, Inc.盘中异动 股价大跌5.71%报0.200美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViracta Therapeutics, Inc.盘中异动 股价大跌5.71%报0.200美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 22:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.18倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b","article_id":"2492966392","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722473395ea3288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492966392","pubTimestamp":1734446853,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","VIRX":"Viracta Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"Viracta Therapeutics, Inc. stock fell 5.71% to $0.200 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"VIRX":1},"content_text":"北京时间2024年12月17日22时47分，Viracta Therapeutics, Inc.（VIRX.us）股票出现波动，股价快速下跌5.71%。截至发稿，该股报0.200美元/股，成交量19.182万股，换手率0.48%，振幅3.73%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.27美元，毛利-110000.00美元，市盈率-0.18倍。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Viracta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Tonix Pharmaceuticals Holding Corp.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为1521.22%、132.20%、94.06%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025(To Pur Com)，振幅分别为98.06%、46.46%、23.99%。Viracta Therapeutics, Inc.公司简介：Viracta Therapeutics Inc 是一家专注于开发针对与病毒相关恶性肿瘤的新药物的精准肿瘤学公司。该公司正在为其组合产品候选药物进行三项临床试验，作为治疗复发/难治性Epstein-Barr病毒阳性淋巴瘤的潜在疗法。该公司的产品候选药物是一种组合产品候选药物，由nanatinostat（一种强效且选择性的I类组蛋白去乙酰化酶（HDAC）小分子抑制剂）和valganciclovir（一种经FDA批准的抗病毒药物，用于治疗和预防器官移植中由巨细胞病毒（CMV）引起的疾病）组成。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492966392"}

Viracta Therapeutics, Inc.盘中异动 股价大跌5.71%报0.200美元

精彩评论

Viracta Therapeutics, Inc.盘中异动股价大跌5.71%报0.200美元